Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

NCT00187109 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Germ Cell Tumors
Hepatic Cancer
Neuroblastoma
Osteosarcoma
Rhabdomyosarcoma

Interventions

DRUG: Recombinant Human Thrombopoietin

Sponsor

St. Jude Children's Research Hospital